loading
Maravai Lifesciences Holdings Inc stock is traded at $2.22, with a volume of 1.18M. It is down -5.13% in the last 24 hours and down -11.55% over the past month. Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
See More
Previous Close:
$2.34
Open:
$2.29
24h Volume:
1.18M
Relative Volume:
0.69
Market Cap:
$319.63M
Revenue:
$288.95M
Net Income/Loss:
$-119.03M
P/E Ratio:
-2.4653
EPS:
-0.9005
Net Cash Flow:
$60.67M
1W Performance:
-17.47%
1M Performance:
-11.55%
6M Performance:
-54.97%
1Y Performance:
-76.95%
1-Day Range:
Value
$2.21
$2.355
1-Week Range:
Value
$2.21
$2.825
52-Week Range:
Value
$1.665
$9.95

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Name
Name
Maravai Lifesciences Holdings Inc
Name
Phone
(858) 546-0004
Name
Address
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Name
Employee
580
Name
Twitter
Name
Next Earnings Date
2025-03-18
Name
Latest SEC Filings
Name
MRVI's Discussions on Twitter

Compare MRVI with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
MRVI
Maravai Lifesciences Holdings Inc
2.22 336.90M 288.95M -119.03M 60.67M -0.9005
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-26-25 Downgrade Robert W. Baird Outperform → Neutral
Dec-19-24 Initiated Guggenheim Neutral
Dec-05-24 Downgrade Goldman Neutral → Sell
Nov-14-24 Initiated Wolfe Research Peer Perform
Nov-08-24 Downgrade William Blair Outperform → Mkt Perform
Aug-28-24 Initiated Wells Fargo Overweight
Aug-13-24 Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-10-24 Initiated Craig Hallum Buy
Dec-12-23 Upgrade BofA Securities Neutral → Buy
Aug-08-23 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
May-23-23 Downgrade Credit Suisse Outperform → Neutral
May-09-23 Downgrade Goldman Buy → Neutral
Jan-05-23 Downgrade UBS Buy → Neutral
Dec-14-22 Initiated Deutsche Bank Buy
Dec-07-22 Initiated RBC Capital Mkts Outperform
Nov-03-22 Downgrade BofA Securities Buy → Neutral
Aug-25-22 Initiated Credit Suisse Outperform
Aug-05-21 Resumed Credit Suisse Outperform
Dec-16-20 Initiated KeyBanc Capital Markets Overweight
Dec-15-20 Initiated BofA Securities Buy
Dec-15-20 Initiated Credit Suisse Outperform
Dec-15-20 Initiated Goldman Buy
Dec-15-20 Initiated Jefferies Buy
Dec-15-20 Initiated Robert W. Baird Outperform
Dec-15-20 Initiated Stifel Buy
Dec-15-20 Initiated William Blair Outperform
Dec-14-20 Initiated UBS Buy
View All

Maravai Lifesciences Holdings Inc Stock (MRVI) Latest News

pulisher
Jul 31, 2025

Wells Fargo Reiterates a Buy Rating on Maravai LifeSciences Holdings (MRVI) - Insider Monkey

Jul 31, 2025
pulisher
Jul 31, 2025

Does Maravai LifeSciences Holdings Inc. stock perform well during market downturnsFinancial News Review For Consistent Profits - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

14 Best Biotech Penny Stocks to Buy Right Now - Insider Monkey

Jul 31, 2025
pulisher
Jul 29, 2025

Why Maravai LifeSciences Holdings Inc. stock attracts strong analyst attention - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-28 23:24:21 - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025 - GlobeNewswire

Jul 28, 2025
pulisher
Jul 28, 2025

Maravai LifeSciences to Announce Second Quarter 2025 Financial Results and Host Conference Call on August 11 - Quiver Quantitative

Jul 28, 2025
pulisher
Jul 28, 2025

Should I hold or sell Maravai LifeSciences Holdings Inc. stock in 2025Breakthrough capital growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is Maravai LifeSciences Holdings Inc. a growth stock or a value stockDiscover high-impact stocks for growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is Maravai LifeSciences Holdings Inc. stock overvalued or undervaluedSuperior stock selection - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are the technical indicators suggesting about Maravai LifeSciences Holdings Inc.Get real-time updates on market trends - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Why is Maravai LifeSciences Holdings Inc. stock attracting strong analyst attentionUnlock powerful investment tools for free - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How does Maravai LifeSciences Holdings Inc. compare to its industry peersCapitalize on strong market momentum - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What is the dividend policy of Maravai LifeSciences Holdings Inc. stockDiscover top stock picks for aggressive growth - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What is the risk reward ratio of investing in Maravai LifeSciences Holdings Inc. stockFree Capital Growth Strategies - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 25, 2025

What drives Maravai LifeSciences Holdings Inc. stock pricePowerful market insights - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc.MRVI - FinancialContent

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Maravai LifeSciences Holdings Inc. stockGame-changing returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Maravai LifeSciences Holdings Inc. a good long term investmentTremendous portfolio expansion - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Maravai LifeSciences Holdings Inc. stock overhyped or has real potentialRapid market gains - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What institutions are buying Maravai LifeSciences Holdings Inc. stock nowFree Trend-Following Techniques - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Maravai LifeSciences Target of Unusually Large Options Trading (NASDAQ:MRVI) - Defense World

Jul 24, 2025
pulisher
Jul 22, 2025

Maravai LifeSciences Holdings Inc. Stock Analysis and ForecastMarket-leading growth rates - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.

Jul 22, 2025
pulisher
Jul 22, 2025

16,587 Shares in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Purchased by Teacher Retirement System of Texas - Defense World

Jul 22, 2025
pulisher
Jul 18, 2025

Maravai LifeSciences appoints Deloitte as new auditor, replaces EY - Investing.com Australia

Jul 18, 2025
pulisher
Jul 18, 2025

Maravai LifeSciences appoints Deloitte as new auditor, replaces EY By Investing.com - Investing.com India

Jul 18, 2025

Maravai Lifesciences Holdings Inc Stock (MRVI) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Cap:     |  Volume (24h):